Box 2: Examples of exemption processes under MEAs.
The Stockholm Convention provides a mechanism for determining time-limited “specific exemptions” and time-unlimited “acceptable purposes” for particular use(s) and production of chemicals otherwise restricted by the Convention’s control measures. The granting of such exemptions is informed by recommendations from the Persistent Organic Pollutants Review Committee (POPRC) based on a risk management evaluation, ensuring a scientifically credible approach to exemptions (see section 5). Should alternatives not exist or not be readily available for regulated substances, Parties can still continue their specific use by registering for a specific exemption or acceptable purpose as per Annexes A and B to the Convention. Article 4 establishes a registry for this purpose, listing the specific exemptions under Annexes A and B, the Parties that have specific exemptions and the expiry dates for each registered exemption. All registrations of specific exemptions expire five years after the Convention entered into force. A review process is in place for each exemption registered and Parties wishing to extend the exemption may submit a report to justify this. The extension may be for up to five years and a Party may withdraw a registry entry at any point, with no new registrations allowed should there no longer be any registrations for a specific exemption. Parties that have registered a specific exemption or acceptable purpose as per Annex A or B must prevent or minimise human exposure and releases to the environment from production or use (Art. 3.6).
Parties to the Montreal Protocol have adopted various Decisions on essential uses. Decision IV/25 provides criteria and procedure for assessing an essential use in relation to Article 2 of the Protocol. The following criteria apply (para. 1):
A use of a controlled substance should qualify as “essential” only if:
it is necessary for the health, safety or is critical for the functioning of society (encompassing cultural and intellectual aspects); and
there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.
Production and consumption, if any, of a controlled substance for essential uses should be permitted only if:
all economically feasible steps have been taken to minimize the essential use and any associated emission of the controlled substance; and
the controlled substance is not available in sufficient quantity and quality from existing stocks of banked or recycled controlled substances, also bearing in mind the developing countries’ need for controlled substances.
Production, if any, for essential use, will be in addition to production to supply the basic domestic needs of the Parties operating under paragraph 1 of Article 5 of the Protocol prior to the phase-out of the controlled substances in those countries.
In addition to defining the criteria for determining “essential use” in Decision IV/25, the Technology and Economic Assessment Panel and its Technical and Economic Options Committee is requested to make recommendations on nominations by Parties based on the above criteria and considering the environmental acceptability, health effects, economic feasibility, availability, and regulatory status of alternatives and substitutes. Recommendations must address:
“the essential use (substance, quantity, quality, expected duration of essential use, duration of production or import necessary to meet such essential use),
economically feasible use and emission controls for the proposed essential use,
sources of already produced controlled substances for the proposed essential use (quantity, quality, timing), and
steps necessary to ensure that alternatives and substitutes are available as soon as possible for the proposed essential use.”